Koh, S., Tham, K., Razvi, K., Oei, P., Lim, F., Roy, A., . . . GYNAECOLOGY, O. &. (2016). Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?
استشهاد بنمط شيكاغوKoh, S.C.L., K.-F Tham, K. Razvi, P.-L Oei, F.-K Lim, A.-C Roy, R.N.V Prasad, و OBSTETRICS & GYNAECOLOGY. Hemostatic and Fibrinolytic Status in Patients With Ovarian Cancer and Benign Ovarian Cysts: Could D-dimer and Antithrombin III Levels Be Included As Prognostic Markers for Survival Outcome? 2016.
MLA استشهادKoh, S.C.L., et al. Hemostatic and Fibrinolytic Status in Patients With Ovarian Cancer and Benign Ovarian Cysts: Could D-dimer and Antithrombin III Levels Be Included As Prognostic Markers for Survival Outcome? 2016.